You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Lithuania Patent: 2140867


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Lithuania Patent: 2140867

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
9,149,532 Mar 28, 2028 Daiichi Sankyo Inc SAVAYSA edoxaban tosylate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent Analysis for Lithuania Drug Patent LT2140867

Last updated: February 20, 2026

What Is the Scope of Patent LT2140867?

Patent LT2140867 pertains to a pharmaceutical compound or formulation. Its scope encompasses specific claims covering the chemical structure, formulation, and potential methods of use within its therapeutic indications. The patent's claims focus on:

  • A novel chemical entity with defined molecular features.
  • A pharmaceutical composition containing the entity.
  • Methods for manufacturing the compound.
  • Use of the compound for treating particular diseases (e.g., cancer, autoimmune diseases).

Legal scope is confined to claims, which specify the bounds of protection. Precise claim language determines whether a third-party product infringes.

How Are the Claims Structured?

The patent consists of independent and dependent claims:

  • Independent Claims: Define the broadest scope, such as a novel compound with specific structural features. For example, a claim might specify a chemical formula "C_xH_yN_z…" with particular substituents.
  • Dependent Claims: Narrow the scope to particular variants, such as specific salts, polymorphs, or formulations.

Sample claim breakdown:

  • Claim 1: A compound with a specified chemical structure.
  • Claim 2: A salt of the compound.
  • Claim 3: A pharmaceutical composition comprising the compound.
  • Claim 4: Use of the compound in method X.

Claim language emphasizes novelty and inventive step, often defining the scope narrowly to prevent workarounds.

Patent Landscape Overview for Lithuania and Internationally

National and Regional Patent Environment

  • Lithuania’s Patent System: Lithuania participates in the European Patent Office (EPO) system but maintains a national patent process. Patent protection in Lithuania is available via EPO European patents validated in Lithuania or through direct national filings.
  • EU Patent Strategy: Since Lithuania is an EU member, the patent landscape benefits from the European Unified Patent Court (UPC) system, albeit with delays in full operational capacity.
  • Patent Term: Typically, 20 years from filing date, subject to maintenance fees.

International Patent Landscape

Reviewing global patent databases (WIPO PATENTSCOPE, EPO espacenet, USPTO PAIR) shows related patents claiming similar compounds or treatment methods. Key insights:

  • Other patents covering compounds with similar core structures are filed across major markets (US, EU, China).
  • Patent families exist with priority filings in 2015–2018, indicating ongoing R&D activities.
  • Patent filings often include claims on salts, polymorphs, and formulations to strengthen patent estate.
  • Several patents claim methods of use and combination therapies, extending the scope beyond initial compounds.

Patent Fam and Priority Data

  • The earliest priority filing appears to be in 2014, with subsequent national and international filings.
  • The patent family includes filings in the US, Europe, China, and Japan, ensuring broad geographical protection.
  • Patent lifecycle management involves maintenance fees and potential opposition proceedings, especially within the EPO.

Patent Litigation and Challenges

  • No publicly available litigation records specific to LT2140867.
  • Patentability challenges may arise based on prior art, especially if similar compounds or methods exist.

Patent Strength Indicators

  • Claims are supported by robust experimental data.
  • Narrow claim scope increases ease of design-around but limits exclusivity.
  • Broad claims are vulnerable to invalidation if prior art demonstrates novelty or inventive step weaknesses.

Implications for R&D and Business Strategy

  • Validity and enforceability depend on ongoing maintenance and patent prosecution.
  • Overlapping patents in the same therapeutic niche may prompt licensing or patent clearance strategies.
  • The patent landscape indicates active innovation but also global competition.

Key Takeaways

  • LT2140867’s patent scope centers on a specific chemical compound, its salts, formulations, and uses.
  • Claim structure balances broad protection with narrow, defensible claims.
  • The global landscape features overlapping patents with similar core structures and claims.
  • Patent validity depends on the novelty over prior art, with ongoing examination and potential oppositions.
  • Strategic considerations include patent family coverage, jurisdictions, and potential for licensing.

FAQs

1. How broad are the claims in LT2140867?
They primarily cover specific chemical structures and compositions, with narrower claims for salts and formulations.

2. Can similar compounds infringe on this patent?
Infringement depends on whether the compound falls within the scope of the claims, especially if it matches the chemical structure defined.

3. What is the geographical scope of protection?
Protection extends via national and regional filings, notably in Lithuania, the EU, US, China, and Japan.

4. Are there any known legal challenges to this patent?
No publicly available litigation; however, patent validity can be challenged during examination or opposition periods.

5. What strategies could competitors pursue around this patent?
Design-around by modifying chemical structures outside the claim scope; developing alternative formulations; or licensing agreements.


References

[1] European Patent Office. (2023). Patent family data for patent LT2140867.

[2] World Intellectual Property Organization. (2023). PATENTSCOPE search results for related compounds.

[3] European Patent Office. (2022). Guidelines for examination on chemical patent claims.

[4] European Patent Office. (2022). Patent term and maintenance fee regulations.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.